Dr. Nelson on Why Patients With mCRC are Often Referred to Surgeons First

In Partnership With:

Douglas A. Nelson, MD, discusses why patients with metastatic colorectal cancer are often referred to surgeons before medical oncologists.

Douglas A. Nelson, MD, associate professor in the Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses why patients with metastatic colorectal cancer (mCRC) are often referred to surgeons before medical oncologists.

Patients with undiagnosed mCRC who are admitted to the hospital for anemia, bleeding, or pain could be referred to a surgeon before being seen by a medical oncologist, says Nelson.

In the outpatient setting, gastroenterologists may diagnose a patient with mCRC, says Nelson. However, if the patient develops an obstruction, the gastroenterologist may refer the patient to a surgeon for resection rather than to a medical oncologist.

According to Nelson, this approach is not always optimal. Certain patients should be seen by a medical oncologist prior to a surgeon.

Related Videos
William M. Sikov, MD
Pannaga G. Malalur, MBBS
Gautam Borthakur, MD
Dimitrios Nasioudis, MD, physician, fellow, gynecologic oncology, Department of Obsetrics and Gynecology, University of Pennsylvania, Penn Medicine
Lindsay K. Buckingham, MD, fellow, gynecologic oncology, Department of Obstetrics and Gynecology, University of North Carolina (UNC) Chapel Hill School of Medicine
Naveen Pemmaraju, MD, an expert on myeloproliferative neoplasms
Pankit Vachhani, MD, an expert on myeloproliferative neoplasms
Brian M. Slomovitz, MD
Shannon N. Westin, MD, MPH, FACOG
Pamela T. Soliman, MD, MPH
Related Content